Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New device aims to keep patients breathing safely during endoscopy

NCT ID NCT07623863

First seen Jun 04, 2026 · Last updated Jun 23, 2026 · Updated 2 times

Summary

This study tests a new device that combines a mouthpiece, airway support, oxygen delivery, and breathing monitoring into one tool for sedated endoscopy. About 1,500 adults will be randomly assigned to receive either this device or standard care. The goal is to see if it reduces episodes of low oxygen during the procedure.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPOXEMIA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Novel Multifunctional Oropharyngeal Airway (device)

What this could lead to

If it works, this device could reduce dangerous drops in oxygen levels during sedated endoscopy, making the procedure safer for patients.

What could go wrong

This is an early-stage trial with no phase designation, so results are uncertain. The device may not perform better than standard care, and risks like discomfort or airway injury are possible.

Conditions

The condition(s) this trial relates to.

Hypoxia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.